PCSK9 inhibitor therapy and guideline treatment targets for cardiovascular disease and familial hypercholesterolaemia - KIVIRID

PCSK9 inhibitor therapy and guideline treatment targets for cardiovascular disease and familial hypercholesterolaemia

Authors: A Suresh, A Theodoraki, E Ward, M D Feher

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.2945

Source: Full article

Abstract

Abstract